Glutamine Synthesis Pathway Promotes the Survival and Recurrence of Dormant Tumor Cells in Prostate Cancer

Investigators reported that the glutamine synthesis pathway is required for cellular dormancy under androgen-deprived conditions. The key enzyme, glutamine synthetase, is upregulated during hormonal therapy, which leads to overabundant glutamine as a nutrient and an energy storage for tumor recurrence.